Leads assessment of developability for gene therapy assets and coordinates with CMC colleagues to communicate risks and mitigation strategies and to transfer research processes and analytical methods In addition to gene therapy work, this role may include contributions to monoclonal antibody and peptide projects from inception to IND enabling studies Maintains broad knowl